期刊文献+

氟尼辛葡甲胺在鸡体内的药物动力学研究 被引量:4

Study on pharmacokinetics of flunixin meglumine after intravenous,intramuscular and oral administration in broilers
下载PDF
导出
摘要 36只健康三黄肉鸡,随机分为3组,进行单次静注、肌注和内服2.2 mg.kg-1氟尼辛葡甲胺,用反相高效液相色谱法测定鸡血浆中氟尼辛葡甲胺的浓度,经3P97药物动力学软件处理血浆药物浓度-时间数据。试验结果表明,静注给药拟合适合二室开放模型,主要动力学参数为:t1/2α:(0.56±0.20)h,t1/2β:(5.98±0.02)h,Vd(area):(0.01±0.003)L.kg-1,CL:(0.03±0.01)L.kg-1.h-1,AUC:(683.00±185.79)μg.h-1.mL-1。肌注和内服给药的药时数据均适合一级吸收二室模型,肌注主要动力学参数为:t1/2α:(0.78±0.04)h,t1/2β:(6.76±0.24)h,Vd(area):(0.01±0.003)L.kg-1,CL:(0.005±0.001)L.kg-1.h-1,AUC:(499.40±130.47)μg.h-1.mL-1,F:73.12%;内服的主要动力学参数是:t1/2α:(0.85±0.11)h,t1/2β:(5.15±0.19)h,Vd(area):(0.02±0.004)L.kg-1,CL:(0.01±0.002)L.kg-1.h-1,AUC:(288.51±74.06)μg.h-1.mL-1,F:42.24%。结果显示:氟尼辛葡甲胺在健康鸡体内的主要药物动力学特征为吸收迅速,达峰时间较短,肌注生物利用度较高,内服生物利用度一般。 Pharmacokineties of flunixin meglumine (FM) was investigated in 36 healthy broilers following single intravenous, intramuscular and oral administration of the drug at the dose of 2.2 mg·kg^-1. Blood samples were collected at different intervals after administration and concentrations of FM were determined by HPLC method with a limit of detection of 0.1 μg·mL^-1. The FM concentration-time data were fitted to a two-compartment open model after single intravenous dosing in broilers. The main pharmacokinetic; parameters were as follows: t1/2α: (0.56±0.20) h, t1/2β: (5.98±0.02) h, Vd (area): (0.01±0.003) L·kg^-1, CL: (0.03±0.01) L·kg^-1·h^-1, AUC: (683.00±185.79) μg·h^-1·mL^-1. The drug concentration-time data were fitted to a two-compartment model with first order absorption after single imtramuseular administration in broilers, The main pharmaeokinectic parameterswereasfollows: t1/2α: (0.78±0.04) h, t1/2β: (6.76±0.24) h, Vd (area): (0.01±0.003) L·kg^-1, CL: (0.005±0.001) L·kg^-1·h^-1, AUC: (499.40±130.47) μg·h^-1·mL^-1, F: 73.12%, Pharmacokinetics of FM following oral administration was described by a two-compartment open model with first order absorption. The main parameters were as follows: t1/2α: (0.85±0.11) h, t1/2β: (5.15±0.19) h, Vd (area): (0.02±0.004) L·kg^-1, CL: (0.01±0.002) L·kg^-1·h^-1, AUC: (288.51±74.06) μg·h^-1·mL^-1, F: 42.24%. The results showed that FM was rapidly absorbed, extensively distributed and slowly eliminated in broilers.
出处 《南京农业大学学报》 CAS CSCD 北大核心 2006年第4期107-110,共4页 Journal of Nanjing Agricultural University
基金 国家自然科学基金项目(30270961) 横向合作课题(Q200601)
关键词 药物动力学 氟尼辛葡甲胺 高效液相色谱 pharmacokineties flunixin meglumine broilers HPLC
  • 相关文献

参考文献14

  • 1British Pharmacopoeia Commission.British Pharmacopoeia(Veterinary)[M].London:The Stationery Office,2001:52
  • 2The United States Pharmacopeial Convention.The United States Pharmacopeia (USP 26th revision)[M].Maryland:The Board of Trustees,2002:799-801
  • 3Adams H R.Veterinary Pharmacology and Therapeutics[M].8th ed.Iowa:Iowa State University Press,2000:442 -443
  • 4Plumb D C.Veterinary Drug Handbook[M].4th ed.Iowa:Iown State Press,2002:368-369
  • 5United States Department of Agriculture,Food Safety and Inspection Service.Determination of Flunixin Cattle Liver by HPLC,CLGFLX1.00[R].Washington,DC:USDA,FSIS,2002
  • 6Odensvik K.Pharmacokinetics of flunixin and its effect on prostaglandin F2 alpha metabolite concentrations after oral and intravenous administration in heifers[J].J Vet Pharmacol Ther,1995,18(4):254-259
  • 7Welsh E M,McKellar Q A,Nolan A M.The pharmacokinetics of flunixin meglumine in the sheep[J].J Vet Pharmacol Ther,1993,16(2):181-188
  • 8Hardie E M,Hardee G E,Rawlings C A.Pharmacokinetics of flunixin meglumine in dogs[J].Am J Vet Res,1985,46:235 -237
  • 9Horii Y,Ikenaga M,Shimoda M,et al.Pharmacokinetics of flunixin in the cat:enterohepatic circulation and active transport mechanism in the liver[J].Am J Vet Res,1990,51 (9):1464-1467
  • 10Hardee G E,Smith J A,Harris S J.Pharmacokinetics of flunixin meglumine in the cow[J].Res Vet Sci,1985,39(1):110-112

二级参考文献19

  • 1British Pharmacopoeia Commission. British Pharmacopoeia (Veterinary)[M]. London:The Stationery office. 2001.P52.
  • 2The United States Pharmacopeial Convention, Inc. The United States Pharmacopeia(USP 26th revision.)[M]. Maryland, 2002.
  • 3Kopcha M, Kaneene JB, Shea ME, et al. Use of nonsteroidal anti-inflammatory drugs in food animal practice[J]. J Am Vet Med Assoc, 1992, 201(12):1868-1872.
  • 4Odensvik K, Cort N, Basu S, et al. Effect of flunixin meglumine on prostaglandin F2 alpha synthesis and metabolism in the pig[J].J Vet Pharmacol Ther, 1989, 12(3):307-11.
  • 5H. Richard Adams. Veterinary Pharmacology and Therapeutics[R]. Eighth Edition. Iowa State University, 2000.
  • 6Donald C Plumb. Veterinary Drug Handbook[M]. Fourth edition. Iowa State Press, 2002. 368-369.
  • 7Hardee GE, Smith JA, Harris SJ. Pharmacokinetics of flunixin meglumine in the cow[J]. Res Vet Sci, 1985, 39(1):110-112.
  • 8Feely WF, Chester-Yansen C, Thompson K, et al. Flunixin residues in milk after intravenous treatment of dairy cattle with (14) C-flunixin[J]. J Agric Food Chem, 2002, 50(25):7308-7313.
  • 9Odensvik K. Pharmacokinetics of flunixin and its effect on prostaglandin F2 alpha metabolite concentrations after oral and intravenous administration in heifers[J]. J Vet Pharmacol Ther, 1995, 18(4):254-259.
  • 10Rantala M, Kaartinen L, Valimaki E, et al. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherchia coli mastitis[J]. J Vet Pharmacol Ther, 2002, 25(4):251-258.

共引文献6

同被引文献36

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部